Table of Contents:
- Clinical implications of measurable residual disease in patients with AML
- The genetic landscape of diffuse large B-cell lymphoma
- Acute graft-versus-host disease: diagnosis, pathophysiology and prevention
- Ibrutinib and bleeding management: a Belgian expert consensus
- Joint BSAC-NVC Congress 2019: A colourful world
- Journal Scan
